Why the study?
Hypertriglyceridemia can lead to serious consequences such as acute pancreatitis and premature atherosclerosis, but consensus for first-line treatment to lower triglyceride levels has not been fully evaluated.
Does intravenous insulin infusion lower triglyceride levels in a patient with very severe hypertriglyceridemia and diabetic ketoacidosis?
Does intravenous insulin infusion lower triglyceride levels in a patient with very severe hypertriglyceridemia and diabetic ketoacidosis?
Intravenous insulin is an effective and minimally invasive treatment to lower high triglyceride levels in patients with concurrent uncontrolled diabetes mellitus and very severe hypertriglyceridemia.
I need the paper's actual verdict and full context before writing the implication. Searching now.Anticipate longer IV insulin for very severe HTG-DKA; confirms case literature but leaves first-line status open.
Hypertriglyceridemia is a common lipid abnormality that has serious consequences, such as acute pancreatitis and premature atherosclerosis. The consensus for first-line treatment to lower the triglyceride levels has not been fully evaluated. We present a case of very severe hypertriglyceridemia with diabetic ketoacidosis and an artifactual pseudohyponatremia. The patient was effectively and safely treated with guideline-directed medical therapy; however, it needed a longer duration of intravenous insulin. Therefore, our case has been in agreement with literature by concluding that insulin is in fact an effective and minimally invasive form to lower a high triglyceride level, especially in patients who have concurrent uncontrolled diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: